Literature DB >> 14623279

Functional characterization of a new human Ad4BP/SF-1 variation, G146A.

Fan WuQiang1, Toshihiko Yanase, Liu Wei, Koichi Oba, Masatoshi Nomura, Taijiro Okabe, Kiminobu Goto, Hajime Nawata.   

Abstract

Ad4BP/SF-1 plays key roles at all levels of the hypothalamic-pituitary-steroidogenic organ axis and its functional disruption causes endocrine disorders of these organs. However, only three human subjects with Ad4BP/SF-1 mutations have been reported to date, suggesting limited clinical significance as a cause of inborn adrenal or sexual abnormalities. We report the first functional characterization of a new variation found in the hinge region of human Ad4BP/SF-1, G146A. Resulting from a single nucleotide shift (GGG-->GCG), G146A bears slightly diminished transactivation activity evidenced by both adrenal specific cyp11A promoter and ovary specific cyp19 promoter II. The variation does not affect protein expression or stability, exhibiting no dominant negative effect. G146A has a normal interaction pattern with standard co-regulators and subnuclear distribution pattern, and can be considered as a nonsynonymous single nucleotide polymorphism, since it occurs in normals and patients with adrenal diseases. In normal Japanese the allele C frequency is 8%, while in a preliminary population of patients with adrenal diseases it is elevated to 30%; suggesting the G146A variation might be of clinical importance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623279     DOI: 10.1016/j.bbrc.2003.10.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development.

Authors:  L Lin; J C Achermann
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

2.  Mutations in NR5A1 associated with ovarian insufficiency.

Authors:  Diana Lourenço; Raja Brauner; Lin Lin; Arantzazu De Perdigo; Georges Weryha; Mihaela Muresan; Radia Boudjenah; Gil Guerra-Junior; Andréa T Maciel-Guerra; John C Achermann; Ken McElreavey; Anu Bashamboo
Journal:  N Engl J Med       Date:  2009-02-25       Impact factor: 91.245

3.  Novel NR5A1 missense mutation in premature ovarian failure: detection in han chinese indicates causation in different ethnic groups.

Authors:  Xue Jiao; Yingying Qin; Guangyu Li; Shidou Zhao; Li You; Jinlong Ma; Joe Leigh Simpson; Zi-Jiang Chen
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 4.  Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.

Authors:  Sorahia Domenice; Aline Zamboni Machado; Frederico Moraes Ferreira; Bruno Ferraz-de-Souza; Antonio Marcondes Lerario; Lin Lin; Mirian Yumie Nishi; Nathalia Lisboa Gomes; Thatiana Evelin da Silva; Rosana Barbosa Silva; Rafaela Vieira Correa; Luciana Ribeiro Montenegro; Amanda Narciso; Elaine Maria Frade Costa; John C Achermann; Berenice Bilharinho Mendonca
Journal:  Birth Defects Res C Embryo Today       Date:  2016-12

5.  SRY and NR5A1 gene mutation in Algerian children and adolescents with DSD and testicular dysgenesis.

Authors:  Naouel Kherouatou-Chaoui; Djalila Chellat-Rezgoune; Mohamed Larbi Rezgoune; Ken Mc Elreavey; Laaldja Souhem Touabti; Noreddine Abadi; Dalila Satta
Journal:  Afr Health Sci       Date:  2021-09       Impact factor: 0.927

6.  A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development.

Authors:  Joyce Y Wu; Ivan N McGown; Lin Lin; John C Achermann; Mark Harris; David M Cowley; Salim Aftimos; Kristen A Neville; Catherine S Choong; Andrew M Cotterill
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

7.  Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Bruno Ferraz-de-Souza; Peter Wieacker; Peter Heidemann; Vanessa Schröder; Heike Biebermann; Dirk Schnabel; Annette Grüters; John C Achermann
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.